private third party payors
“10-K Item 1A: 'Revenues derived from private third party payors accounted for 44.3% and 43.5% of our revenues for 2025 and 2024, respectively.'”
Updated
The most significant concentration Ardent Health discloses is private third party payors at 44.3%, classified MEDIUM by disclosed size. Below: the full set from the latest 10-K — verbatim quotes, filing references, and a synthesis of what these exposures mean together.
Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results.
About TrendMatrix. TrendMatrix is a publisher of general securities research and market commentary. We publish on a regular schedule. All content is the same for every subscriber in a tier — we do not provide personalized investment advice and we do not take into account any individual subscriber's financial situation, investment objectives, risk tolerance, tax situation, or holdings.
Not investment advice. TrendMatrix is not a registered investment adviser. Our content is for informational and educational purposes only. Consult your own licensed investment adviser, broker, or tax professional before making any investment decision.
Conflicts and positions. The TrendMatrix editorial team frequently holds personal long-term positions in securities discussed. We disclose positions held at the time of publication on each piece. We maintain a trading-window policy: we do not initiate or close positions in the same direction as a TrendMatrix publication within 24 hours before or 72 hours after publication.
No paid promotion. TrendMatrix does not accept payment from any issuer, broker, or third party in exchange for coverage of any security. Our sole compensation is subscription revenue.
No fiduciary duty. No fiduciary, advisory, or agency relationship is created between you and TrendMatrix by reading our content or subscribing to our service.
Performance. Past performance is not indicative of future results. Performance figures reflect the published model only and do not reflect any individual subscriber's actual results.
Source: Ardent Health’s SEC Form 10-K filed — view the filing on SEC EDGAR ↗
Each card carries a disclosed-size chip (HIGH / MEDIUM / LOW — how large the exposure is as a share of revenue, not how dangerous it is) and a nature tag: Built-in(the company’s own model, geography, or products) or Outside party (an external customer, supplier, or distributor it relies on).
“10-K Item 1A: 'Revenues derived from private third party payors accounted for 44.3% and 43.5% of our revenues for 2025 and 2024, respectively.'”
“10-K Item 1A: 'our facilities are heavily concentrated in Texas and Oklahoma, which makes us sensitive to regulatory, economic and competitive conditions and changes in those states'”
Ardent Health's concentration risk runs through both payor mix and geography, and both are medium-share exposures. Private third-party payors accounted for 44.3% of revenues in the most recent year, essentially steady versus 43.5% the year before — a dependency-type exposure tied to commercial payor contracting and reimbursement rates rather than a structural feature of the underlying business. Separately, the company's facilities are heavily concentrated in Texas and Oklahoma, a structural, medium-share geographic footprint that makes results sensitive to regulatory, economic, and competitive conditions specific to those two states. These two exposures differ in kind — one is a dependency on how payors negotiate and reimburse, the other is baked into where the hospitals physically sit — but they can compound in a downturn: a state-specific economic or regulatory shock in Texas or Oklahoma could pressure both patient volumes and payor mix simultaneously. Neither exposure, on the numbers disclosed, looks large enough on its own to be a decisive swing factor, but together they mean Ardent's results are more sensitive to regional economic conditions and payor dynamics than a more geographically or payor-diversified peer would be.
For the engine’s reasoning on ARDT’s current verdict — including which dimensions drove the score — see the per-dimension breakdown.
| Symbol | Name | HIGH | MEDIUM | LOW | Total |
|---|---|---|---|---|---|
| ACHC | Acadia Healthcare Company, Inc. | 1 | 1 | 0 | 2 |
| ADUS | Addus HomeCare Corporation | 0 | 2 | 4 | 6 |
| ARDT● | Ardent Health, Inc. | 0 | 2 | 0 | 2 |
| ASTH | Astrana Health Inc. | 0 | 1 | 0 | 1 |
| AMN | AMN Healthcare Services Inc | 0 | 0 | 1 | 1 |
| AGL | agilon health, inc. | 0 | 0 | 0 | 0 |
Concentration counts reflect items disclosed in each peer’s most recent 10-K; disclosed-size classification uses TrendMatrix’s internal 10-K extraction taxonomy.